Reverse Stock Split Strengthens HealthLynked鈥檚 Market Position as Company Scales AI-Driven Healthcare Platform
HealthLynked (OTCQB: HLYK) has completed a strategic reverse stock split to strengthen its market position and capital structure. The company aims to improve visibility and access to institutional investors while maintaining shareholders' percentage ownership. This move is part of HealthLynked's broader strategy to support potential uplisting opportunities.
The company has recently launched ARi, its patented AI healthcare guide, and is expanding its nationwide telemedicine platform. HealthLynked is in discussions with major insurance carriers for integrating its technology into care management workflows, which could generate substantial recurring revenue. The company is also expanding its intellectual property portfolio in healthcare and AI technologies.
HealthLynked (OTCQB: HLYK) ha completato una reverse split azionaria strategica per rafforzare la propria posizione di mercato e la struttura patrimoniale. L'operazione mira a migliorare la visibilit脿 e l'accesso agli investitori istituzionali, preservando la percentuale di partecipazione degli azionisti. Questa iniziativa fa parte della strategia pi霉 ampia di HealthLynked per agevolare eventuali opportunit脿 di uplisting.
La societ脿 ha recentemente lanciato ARi, la sua guida sanitaria brevettata basata sull'AI, e sta ampliando la piattaforma di telemedicina su scala nazionale. HealthLynked 猫 in trattativa con importanti compagnie assicurative per integrare la sua tecnologia nei flussi di gestione della cura, potenzialmente generando ricavi ricorrenti significativi. Inoltre, sta espandendo il proprio portafoglio di propriet脿 intellettuale nel settore sanitario e nelle tecnologie AI.
HealthLynked (OTCQB: HLYK) ha llevado a cabo una reversi贸n de acciones estrat茅gica para fortalecer su posici贸n en el mercado y su estructura de capital. La compa帽铆a busca aumentar su visibilidad y acceso a inversores institucionales, manteniendo el porcentaje de participaci贸n de los accionistas. Esta medida forma parte de la estrategia m谩s amplia de HealthLynked para facilitar posibles oportunidades de uplisting.
Recientemente, la empresa lanz贸 ARi, su gu铆a sanitaria patentada basada en IA, y est谩 ampliando su plataforma de telemedicina a nivel nacional. HealthLynked est谩 en conversaciones con importantes aseguradoras para integrar su tecnolog铆a en los flujos de gesti贸n del cuidado, lo que podr铆a generar ingresos recurrentes sustanciales. Tambi茅n est谩 ampliando su cartera de propiedad intelectual en salud y tecnolog铆as de IA.
HealthLynked (OTCQB: HLYK)電� 鞁滌灔 歆�鞙勳檧 鞛愲掣 甑“毳� 臧曧檾頃橁赴 鞙勴暣 鞝勲灥鞝� 鞐硲頃�(毽矂鞀� 鞀ろ攲毽�)鞚� 鞕勲頄堨姷雼堧嫟. 鞚� 臁办箻電� 旮瓣磤 韴瀽鞛愳棎 雽�頃� 臧�鞁滌劚瓿� 鞝戧芳靹膘潉 雴掛澊電� 霃欖嫓鞐� 欤检＜霌れ潣 氤挫湢 牍勳湪鞚� 鞙犾頃橂姅 瓴冹潉 氇╉憸搿� 頃╇媹雼�. 鞚措矆 瓴办爼鞚� 頄ロ泟 靸侅灔 霌标笁 靸來枼(uplisting) 臧�電レ劚鞚� 歆�鞗愴晿旮� 鞙勴暅 HealthLynked鞚� 甏戨矓鞙勴暅 鞝勲灥鞚� 鞚柬櫂鞛呺媹雼�.
須岇偓電� 斓滉芳 韸鬼棃 氤挫湢 AI 項姢旒�鞏� 臧�鞚措摐鞚� ARi毳� 於滌嫓頄堨溂氅�, 鞝勱淡 雼渼鞚� 鞗愱博鞚橂 頂岆灚韽检潉 頇曥灔頃橁碃 鞛堨姷雼堧嫟. HealthLynked電� 欤检殧 氤错棙靷摛瓿� 旮办垹鞚� 旃橂 甏�毽� 鞗岉伂頂岆鞐� 韱淀暕頃橂姅 氚╈晥鞚� 雲检潣 欷戩澊氅�, 鞚措姅 靸侂嫻頃� 氚橂车 靾橃澋 彀届稖搿� 鞚挫柎歆� 靾� 鞛堨姷雼堧嫟. 霕愴暅 項姢旒�鞏� 氚� AI 旮办垹 甏�霠� 歆�鞝侅灛靷� 韽姼韽措Μ鞓る弰 頇曥灔頃橁碃 鞛堨姷雼堧嫟.
HealthLynked (OTCQB: HLYK) a finalis茅 une division inverse d'actions strat茅gique afin de renforcer sa position sur le march茅 et sa structure de capital. L'op茅ration vise 脿 accro卯tre la visibilit茅 et l'acc猫s aux investisseurs institutionnels tout en maintenant le pourcentage de participation des actionnaires. Cette d茅marche s'inscrit dans la strat茅gie globale de HealthLynked pour soutenir d'茅ventuelles opportunit茅s d'up-listing.
La soci茅t茅 a r茅cemment lanc茅 ARi, son guide de sant茅 brevet茅 bas茅 sur l'IA, et 茅tend sa plateforme nationale de t茅l茅m茅decine. HealthLynked est en discussions avec de grands assureurs pour int茅grer sa technologie dans les processus de gestion des soins, ce qui pourrait g茅n茅rer des revenus r茅currents importants. Elle enrichit 茅galement son portefeuille de propri茅t茅 intellectuelle dans les domaines de la sant茅 et des technologies d'IA.
HealthLynked (OTCQB: HLYK) hat eine strategische Reverse-Stock-Split durchgef眉hrt, um seine Marktposition und Kapitalstruktur zu st盲rken. Ziel der Ma脽nahme ist es, die Sichtbarkeit und den Zugang f眉r institutionelle Investoren zu verbessern und gleichzeitig die prozentuale Eigent眉merstellung der Aktion盲re zu erhalten. Dieser Schritt ist Teil der umfassenderen Strategie von HealthLynked zur Unterst眉tzung m枚glicher Uplisting-Chancen.
Das Unternehmen hat k眉rzlich ARi, seinen patentierten KI-basierten Gesundheitsratgeber, eingef眉hrt und baut seine landesweite Telemedizin-Plattform aus. HealthLynked steht in Gespr盲chen mit gro脽en Versicherern 眉ber die Integration seiner Technologie in das Care-Management, was erhebliche wiederkehrende Einnahmen erzeugen k枚nnte. Zudem erweitert das Unternehmen sein geistiges Eigentum im Bereich Gesundheit und KI-Technologien.
- Non-dilutive reverse split maintains shareholders' percentage ownership
- Potential uplisting opportunities and broader investor access
- Recently launched patented AI healthcare guide (ARi)
- Ongoing discussions with major insurance carriers for technology integration
- Expanding intellectual property portfolio in healthcare and AI
- Early stage of revenue generation
- Currently trading on OTCQB market, indicating lower tier listing
- Implementation of reverse split suggests previous low share price concerns
NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB:聽) -- Dear Shareholders,
I'm writing to share an important update in the continued evolution of HealthLynked Corp. that reflects our commitment to long-term growth and enhanced shareholder value.
We've completed a strategic reduction in the number of our outstanding shares. This move鈥攃ommonly referred to as a reverse stock split鈥攊s part of a broader effort to strengthen our capital structure, improve our market positioning, and align HealthLynked with the expectations of institutional investors and national trading platforms.
Why This Matters
By reducing the number of shares outstanding, we've increased our per-share price without impacting your percentage ownership in the Company. This is a non-dilutive step that supports greater visibility, potential uplisting opportunities, and access to a broader range of investors鈥攊ncluding those using trading platforms that require a minimum share price for participation.
This approach has been used successfully by many emerging growth companies preparing for a larger market presence, and we believe it puts HealthLynked on a similar path.
Built for Growth, Ready to Scale
We've recently launched our patented AI healthcare guide, ARi, and we continue to build commercial traction through our nationwide telemedicine platform and other digital services. While early in revenue generation, these platforms are gaining momentum and positioning us for scalable deployment.
We are currently in discussions with major insurance carriers to integrate our technology into care management workflows鈥攁 model that could drive substantial recurring revenue across large member populations. At the same time, we are expanding our intellectual property portfolio, building on our existing patents in healthcare and AI to support future innovation and defensible market leadership.
Looking Ahead
The reduction in our outstanding shares is just one step in a larger plan to enhance shareholder value, attract institutional support, and scale our operations. Our vision is bold, and our technology is built for impact. We remain focused on executing that vision while keeping the long-term interests of our shareholders front and center.
Thank you for your continued trust and support. We look forward to sharing more progress with you in the months ahead.
Sincerely,
Michael Dent M.D.
Chief Executive Officer
HealthLynked Corp.
About HealthLynked Corp
HealthLynked Corp. enhances healthcare through personalized care management that improves outcomes and reduces costs. Its cloud-based platform connects patients with providers for virtual or in-office appointments and consolidates medical records into one secure, accessible location.
With AI-driven insights and integrated telehealth services, HealthLynked empowers patients and providers to coordinate care more effectively, while delivering substantial savings on prescriptions and healthcare services. The platform supports enterprise partnerships, offering scalable solutions to healthcare networks and digital health innovators.
Learn more at:聽
Download the HealthLynked App:
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such statements are inherently uncertain and may differ materially from actual results. Forward-looking statements reflect management's current expectations and are subject to risks, uncertainties, and assumptions. HealthLynked disclaims any obligation to update these statements except as required by law.
Investor & Media Contact
HealthLynked Corp.
1265 Creekside Parkway, Suite 200
Naples, FL 34108
Phone: +1 (800) 928-7144
贰尘补颈濒:听
FAQ
What is the purpose of HealthLynked's (HLYK) reverse stock split in 2025?
How will the HLYK reverse stock split affect shareholders?
What are HealthLynked's (HLYK) main products and growth drivers?
What is HealthLynked's (HLYK) strategy for future growth?
What stage of revenue generation is HealthLynked (HLYK) currently in?
